Catalog No.
Product Name
Application
Product Information
Citations
-
S1P1 Receptor Agonist
ACT-209905 is an agonist of the S1P1 receptor, demonstrating potent inhibition of glioblastoma (GBM) cell growth and migration. In addition to its antitumor properties, ACT-209905 exhibits immunomodulating activity, making it a valuable tool for investigating autoimmune diseases. This compound is suitable for research applications aimed at elucidating the roles of S1P1 signaling in cancer and immune regulation. -
S1P1 Receptor Partial Agonist
BMS-986104 hydrochloride is a selective partial agonist of the S1P1 receptor, involved in modulating sphingosine-1-phosphate signaling pathways. This compound exhibits potential therapeutic effects in the context of autoimmune diseases by influencing lymphocyte trafficking and immune response. It serves as a valuable tool for research aimed at understanding and developing treatments for various autoimmune disorders.
